Norditropin FlexPro 5 mg

Norditropin FlexPro 5 mg is a medicine authorised by Swissmedic under authorisation number 60469. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 June 2010 and the authorisation is valid without a time limit. ATC code H01AC01 places the medicine in the group Pituitary and hypothalamic hormones and analogues.

  • Dispensing category A
  • Authorisation number 60469
  • ATC H01AC01
  • Biotechnological medicines
Authorisation data
Authorisation number60469
NameNorditropin FlexPro 5 mg
Full nameNorditropin FlexPro 5 mg, Injektionslösung im Fertigpen
Authorisation holderNovo Nordisk Pharma AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeH01AC01
First authorisation18 June 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Norditropin FlexPro 5 mg, Injektionslösung im FertigpenA18 June 2010
2Norditropin FlexPro 10 mg, Injektionslösung im FertigpenA18 June 2010
3Norditropin FlexPro 15 mg, Injektionslösung im FertigpenA18 June 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11SetH01AC0107.03.1.A
21SetH01AC0107.03.1.A
31SetH01AC0107.03.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Norditropin FlexPro 5 mg authorised in Switzerland?

Yes. Norditropin FlexPro 5 mg is authorised by Swissmedic under authorisation number 60469, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Norditropin FlexPro 5 mg have?

Norditropin FlexPro 5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Norditropin FlexPro 5 mg?

The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com